SARS-CoV-2-IN-25 (disodium)

SARS-CoV-2-IN-25 (disodium)

• UNSPSC Description: SARS-CoV-2-IN-25 (Compound CP026) disodium is a potent SARS-CoV-2 spike pseudoparticle transduction inhibitor with an IC50 of 1.6 μM. SARS-CoV-2-IN-25 disodium inhibits enveloped viruses and liposomes[1].
• Target Antigen: SARS-CoV
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/sars-cov-2-in-25-disodium.html
• Solubility: 10 mM in DMSO
• Smiles: O=P(OCCC1=CC=CC=C1)(O[Na])OC(C2=C3C4C5=CC(C6CC7C8=C6C=CC=C8)=C7C=C5C2C4)=C(C9C%10=C(C%11C9)C=C%12C(C%13C%14=C(C%12C%13)C=CC=C%14)=C%10)C%11=C3OP(OCCC%15=CC=CC=C%15)(O[Na])=O
• Molecular Weight: 978.91
• References & Citations: [1]Weil T, et al. Advanced Molecular Tweezers with Lipid Anchors against SARS-CoV-2 and Other Respiratory Viruses. JACS Au, 2022.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported